» Articles » PMID: 20880986

Estrogen Receptor-alpha Promotes Breast Cancer Cell Motility and Invasion Via Focal Adhesion Kinase and N-WASP

Overview
Journal Mol Endocrinol
Date 2010 Oct 1
PMID 20880986
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of cancer cells to move and invade the surrounding environment is the basis of local and distant metastasis. Cancer cell movement requires dynamic remodeling of the cytoskeleton and cell membrane and is controlled by multiprotein complexes including focal adhesion kinase (FAK) or the Neural Wiskott-Aldrich Syndrome Protein (N-WASP). We show that 17β-estradiol induces phosphorylation of FAK and its translocation toward membrane sites where focal adhesion complexes are assembled. This process is triggered via a Gα/Gβ protein-dependent, rapid extranuclear signaling of estrogen receptor α interacts in a multiprotein complex with c-Src, phosphatidylinositol 3-OH kinase, and FAK. Within this complex FAK autophosphorylation ensues, and activated FAK recruits the small GTPase cdc42, which, in turn, triggers N-WASP phosphorylation. This results in the translocation of Arp2/3 complexes at sites where membrane structures related to cell movement are formed. Recruitment of FAK and N-WASP is necessary for cell migration and invasion induced by 17β-estradiol in breast cancer cells. Our findings identify an original mechanism through which estrogen promotes breast cancer cell motility and invasion. This information helps to understand the effects of estrogen on breast cancer metastasis and may provide new targets for therapeutic interventions.

Citing Articles

A reappraisal of cell cycle phase enrichment in synchronized estrogen receptor-positive cell models derived from breast adenocarcinomas.

Toker P, Ayten H, Demiralay O, Binarci B, Turan G, Olgun C Sci Rep. 2025; 15(1):5949.

PMID: 39966575 PMC: 11836305. DOI: 10.1038/s41598-025-90456-8.


Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor.

Nagandla H, Thomas C Receptors (Basel). 2024; 3(2):182-200.

PMID: 39175529 PMC: 11340209. DOI: 10.3390/receptors3020010.


WASP family proteins: Molecular mechanisms and implications in human disease.

Kramer D, K Piper H, Chen B Eur J Cell Biol. 2022; 101(3):151244.

PMID: 35667337 PMC: 9357188. DOI: 10.1016/j.ejcb.2022.151244.


Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis.

Mohammadi Ghahhari N, Sznurkowska M, Hulo N, Bernasconi L, Aceto N, Picard D Nat Commun. 2022; 13(1):2104.

PMID: 35440541 PMC: 9018728. DOI: 10.1038/s41467-022-29723-5.


Expression Profiles of Estrogen-Regulated MicroRNAs in Cancer Cells.

Archer A, Kutter C, Williams C Methods Mol Biol. 2022; 2418:313-343.

PMID: 35119673 DOI: 10.1007/978-1-0716-1920-9_18.


References
1.
Mitra S, Hanson D, Schlaepfer D . Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005; 6(1):56-68. DOI: 10.1038/nrm1549. View

2.
Mullins R, Heuser J, Pollard T . The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. Proc Natl Acad Sci U S A. 1998; 95(11):6181-6. PMC: 27619. DOI: 10.1073/pnas.95.11.6181. View

3.
Luo M, Fan H, Nagy T, Wei H, Wang C, Liu S . Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res. 2009; 69(2):466-74. PMC: 3039129. DOI: 10.1158/0008-5472.CAN-08-3078. View

4.
Horwitz K . The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk. Mol Endocrinol. 2008; 22(12):2743-50. PMC: 2626201. DOI: 10.1210/me.2008-0291. View

5.
Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson N, Gazet J . Estrogen and progesterone receptors in the normal female breast. Cancer Res. 1991; 51(7):1817-22. View